Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Reiner

Showing results (311-320 of 354) with videos related to

Pageof 36
Sort By:
Nature Plants|November 16, 2021
The root meristem is shaped by brassinosteroid control of cell geometryY Fridman, S Strauss, G Horev, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
HER-2 oncogene amplification and overall survival of breast carcinoma patientsF Kury, G Sliutz, M Schemper, et al.
Connective Tissue Research|April 11, 2000
Mature full-thickness articular cartilage explants attached to bone are physiologically stable over long-term culture in serum-free mediaJ Dumont, M Ionescu, A Reiner, et al.
The Journal of Biological Chemistry|May 25, 1985
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilagesL C Rosenberg, H U Choi, L H Tang, et al.
Gynecologic Oncology|June 1, 1994
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA C Rosen, A Reiner, M Klein, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
British Journal of Cancer|July 1, 1995
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancerM Fiegl, C Tueni, T Schenk, et al.
The American Journal of Medicine|December 1, 1988
Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19L J Deftos, W Woloszczuk, I Krisch, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patientsE M Kittl, R Ruckser, S Selleny, et al.
Oncology|September 1, 1995
HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube CarcinomaM Stühlinger, A C Rosen, K Dobianer, et al.
Pageof 36

Showing results (311-320 of 354) with videos related to

Sort By:
Pageof 36
Nature Plants|November 16, 2021
The root meristem is shaped by brassinosteroid control of cell geometryY Fridman, S Strauss, G Horev, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
HER-2 oncogene amplification and overall survival of breast carcinoma patientsF Kury, G Sliutz, M Schemper, et al.
Connective Tissue Research|April 11, 2000
Mature full-thickness articular cartilage explants attached to bone are physiologically stable over long-term culture in serum-free mediaJ Dumont, M Ionescu, A Reiner, et al.
The Journal of Biological Chemistry|May 25, 1985
Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilagesL C Rosenberg, H U Choi, L H Tang, et al.
Gynecologic Oncology|June 1, 1994
Prognostic factors in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube CarcinomaA C Rosen, A Reiner, M Klein, et al.
British Journal of Cancer|March 1, 1994
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancerA C Rosen, P Sevelda, M Klein, et al.
British Journal of Cancer|July 1, 1995
Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancerM Fiegl, C Tueni, T Schenk, et al.
The American Journal of Medicine|December 1, 1988
Medullary thyroid carcinomas express chromogranin A and a novel neuroendocrine protein recognized by monoclonal antibody HISL-19L J Deftos, W Woloszczuk, I Krisch, et al.
Experimental and Clinical Immunogenetics|January 1, 1997
Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patientsE M Kittl, R Ruckser, S Selleny, et al.
Oncology|September 1, 1995
HER-2 oncogene is not amplified in primary carcinoma of the fallopian tube. Austrian Cooperative Study Group for Fallopian Tube CarcinomaM Stühlinger, A C Rosen, K Dobianer, et al.
Pageof 36